A new paper has suggested that pay-for-delay deals could be replaced with a challenger-based system to improve access to generic drugs.
List view / Grid view
University of East Anglia
Filter the results
The changes could prevent anticompetitive practices between branded and generic pharmaceutical manufacturers, lowering drug prices for consumers.
A new antibiotic, produced by bacteria found on a species of African ant, is very potent against antibiotic-resistant ‘superbugs’ like MRSA according to scientists.